Results 101 to 110 of about 4,412 (151)

De novo myasthenia gravis in a patient with malignant melanoma after concurrent SARS-CoV-2 vaccination and immune checkpoint inhibitor therapy:Case report and literature review [PDF]

In recent years, the advent and increasingly common use of immune checkpoint inhibitors (ICIs) in cancer treatment have been notable. While ICIs have shown relatively better toxicity profiles compared to traditional chemotherapy agents, they are linked ...
Fadavi, Pedram, Ramandi, Mohammad Mostafa Ansari, Shahin, Mohadese, Shahrokh, Soroush, Taghizadeh-Hesary, Farzad   +4 more
core   +1 more source

Immunogenicity of two‐dose sinopharm BBIB‐CorV vaccine in Morocco: One‐year follow‐up and neutralizing activity against severe acute respiratory syndrome coronavirus 2 variants of concern

Immunity, Inflammation and Disease, Volume 12, Issue 11, November 2024.
This study assessed the immune response to the Sinopharm BBIB‐CorV vaccine against SARS‐CoV‐2 over a period of 1 year, using a two‐dose regimen. Conducted at the Military Hospital of Rabat, Morocco, the study found that additional booster vaccinations may be necessary based on the observed immunogenicity against various virus variants.
Maha Ouarab, Elarbi Bouaiti, Zineb Rhazzar, Hicham El Annaz, Safae el kochri, Mouhssine Hemlali, Hamza Ghammaz, Omar Nyabi, Karim el Bakkouri, Nadia Touil, Mostafa Elouennass, Lamiae Belayachi, Jean Luc Gala, Khalid Ennibi, Elmostafa El Fahime   +14 more
wiley   +1 more source

SARS‐CoV‐2 Evolution: Immune Dynamics, Omicron Specificity, and Predictive Modeling in Vaccinated Populations

Advanced Science, Volume 11, Issue 40, October 28, 2024.
This study analyzes the co‐evolution of SARS‐CoV‐2 mutation, ACE2 receptor binding, and NAb responses across various variants using SARS‐CoV‐2 broad neutralizing antibody (bNAb) assay. The results reveal the link between vaccine efficacy and vaccine type, dosing, and the hybrid vaccination combining the WT inactivated vaccine with the Omicron BA.4/5 ...
Xiaohan Zhang, Mansheng Li, Nana Zhang, Yunhui Li, Fei Teng, Yongzhe Li, Xiaomei Zhang, Xingming Xu, Haolong Li, Yunping Zhu, Yumin Wang, Yan Jia, Chengfeng Qin, Bingwei Wang, Shubin Guo, Yajie Wang, Xiaobo Yu   +16 more
wiley   +1 more source

Humoral and cellular immunogenicity and safety of five different SARS-CoV-2 vaccines in patients with autoimmune rheumatic and musculoskeletal diseases in remission or with low disease activity and in healthy controls: a single center study [PDF]

, 2022
Balog József Ágoston, Balogd Attila, Gémes Nikolett, Honfi Dániel György, Nagy Lajos I., Neuperger Patricia, Puskás László, Szabó Enikő, Szebeni Gábor, Szekanecz Zoltán, Toldi Gergely   +10 more
core   +1 more source

Effects of BBIBP-CorV vaccine on gut microbiota and short-chain fatty acids in mice exposed to bis (2-ethylhexyl) phthalate and dioctyl terephthalate

Environment International
As the COVID-19 pandemic has progressed, increasing evidences suggest that the gut microbiota may play a crucial role in the effectiveness of SARS-CoV-2 vaccine.
Miaomiao Teng, Jiaqi Sun, Lihui Zhao, Yunxia Li, Zixuan Zhang, Wentao Zhu, Yuntao Zhang, Fangjingwei Xu, Sixi Xing, Xiaoli Zhao, Fengchang Wu   +10 more
doaj   +1 more source

Immunogenicity and Safety of Heterologous Versus Homologous Prime-Boost Regimens With BBIBP-CorV and Ad26.COV2.S COVID-19 Vaccines: A Multicentric, Randomized, Observer-Blinded Non-inferiority Trial in Madagascar and Mozambique [PDF]

Background Data on immunogenicity and safety of heterologous prime-boost (HePB) regimens using the BBIBP-CorV and Ad26.COV2.S have not yet been reported in sub-Saharan Africa. Methods

core   +1 more source

A real-world study on the effectiveness of BBIBP-CorV and CoronaVac in Nanjing area. [PDF]

Sci Rep, 2023
Huang M, Jia L, Ye S, Pang R, Ma C, Zhang J, Dai S, Zhang K, Dai Y, Fu Q, Zhang L.   +10 more
europepmc   +1 more source

Safety and efficacy of COVID-19 prime-boost vaccinations: Homologous BBIBP-CorV versus heterologous BNT162b2 boosters in BBIBP-CorV-primed individuals. [PDF]

Vaccine, 2023
Mallah SI, Alawadhi A, Jawad J, Wasif P, Alsaffar B, Alalawi E, Mohamed AM, Butler AE, Alalawi B, Qayed D, Almahari SA, Mubarak A, Mubarak A, Saeed S, Humaidan A, Kumar N, Atkin S, Alqahtani M.   +17 more
europepmc   +1 more source

Cord blood antibodies following BBIBP-CorV (Sinopharm) vaccination during pregnancy. [PDF]

Immun Inflamm Dis, 2023
Hantoushzadeh S, Eshraghi N, Younesi S, Salehi M, Rezaei N, Hasheminejad MM, Rashidian P, Shirdel S, Asadi F, Ghaemi M.   +9 more
europepmc   +1 more source

COVID-19 inactivated booster vaccines elicit strong protection against SARS-CoV-2 wild-type and Omicron variant in patients with breast cancer [PDF]

BackgroundPatients with breast cancer are at an increased risk of severe COVID-19 and related mortality. However, the ability of inactivated vaccine-induced antibodies to neutralize both SARS-CoV-2 and its Omicron variant following a third SARS-CoV-2 ...
Haolong Li, Haoting Zhan, Linrong Li, Qiang Sun, Xiaomeng Li, Xiaomeng Li, Yali Xu, Yongmei Liu, Yongzhe Li   +8 more
core   +1 more source